Immorta Bio files Form D for $5 million equity offering
The Delaware biotechnology company reported $612,503 raised from six investors as of a filing dated October 16, 2026.
SEC filing
Latest
1 story
Sign inSign in1 story
The Delaware biotechnology company reported $612,503 raised from six investors as of a filing dated October 16, 2026.
SEC filing